The chronically infarcted rat heart has multiple defects in metabolism, yet the location of the primary metabolic abnormality arising after myocardial infarction is unknown. Therefore, we investigated cardiac mitochondrial metabolism shortly after infarction.
Introduction
Following myocardial infarction, the heart becomes energetically compromised with reduced phosphocreatine and ATP concentrations. 1, 2 In the healthy heart, most ATP is generated from the mitochondrial oxidation of fatty acids, 3 but in the chronically infarcted rat heart, fatty acid oxidation rates are reduced. 4 The decreased fatty acid oxidation rates in the infarcted heart correlate positively with cardiac function; 4, 5 hence, the lowest rates of fatty acid metabolism are present in hearts that are in failure. 4 The decreased fatty acid oxidation in the chronically infarcted heart is associated with multiple defects in a number of metabolic pathways, with abnormalities in proteins involved in b-oxidation, the Krebs cycle, and the electron transport chain (ETC). 4, 6, 7 Whether this is a synchronized down-regulation of multiple proteins in the infarcted heart, or if the metabolic defect initially arises from one specific protein, remains to be determined. Investigating mitochondrial metabolism during the acute remodelling period following myocardial infarction would identify the initial metabolic defect that occurs in the infarcted heart.
Within the heart, there are two morphologically and biochemically distinct populations of mitochondria; subsarcolemmal mitochondria (SSM) and interfibrillar mitochondria (IFM). 8 Although both are essential for ATP generation, the two populations differ in their cristae structure, rates of respiration, and expression of metabolic proteins. 9 -11 In the canine intracoronary microembolization model of heart failure, respiration rates in SSM and IFM are reduced compared with controls. 12 In contrast, in a rodent model of myocardial infarction, respiration rates in SSM and IFM are not significantly impaired relative to sham-operated control rats. 13 In the latter study, the contractile impairment induced by myocardial infarction was modest, which the authors suggest represents a mild cardiac dysfunction. 13 Whether SSM and IFM respiration rates are impaired in failing rat hearts following myocardial infarction, and whether the severity of infarction predisposes to a greater malfunction in mitochondrial metabolism, is currently unclear.
Reactive oxygen species (ROS) can be generated from complexes I and III of the mitochondrial ETC and have been implicated in oxidative damage to mitochondria during ischaemia. 14 An early target for oxidative damage by ROS is cardiolipin, a highly unsaturated phospholipid localized almost exclusively within the mitochondrial inner membrane, which is essential for optimal ETC activity. 15 Whether ETC-derived ROS generation and cardiolipin peroxidation are involved in metabolic dysfunction in the acute remodelling period following myocardial infarction has not been fully determined. In this study, rats underwent myocardial infarction and sham operation and, at 2 weeks post-surgery, were divided into groups according to the severity of cardiac dysfunction. Mitochondrial respiration was measured in cardiac SSM and IFM, and was complemented by measurements of metabolic proteins, enzymes, cardiolipin, and ROS generation. We aimed to identify the primary mitochondrial metabolic defect following acute myocardial infarction, and to study the relationship between contractile and mitochondrial dysfunction.
Methods

Rat model of myocardial infarction
Male Wistar rats (n ¼ 20) were obtained from a commercial breeder (Harlan, UK). The investigation conforms with the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health (NIH Publication No. 85-23, revised 1996), and approval was granted by the local committee on Animal Care and Ethical Review (ACER) and The University of Oxford's Local Ethical Review Process. Myocardial infarction was induced by permanent occlusion of the left anterior descending (LAD) coronary artery, as described previously. 16 Briefly, rats were anaesthetized and intubated, and a thoracotomy was performed to access the heart. The LAD was ligated 2 mm from the origin, using a 5-0 proline suture (n ¼ 11). In sham-operated control rats (n ¼ 9), the same procedure was followed, but the ligation suture was not placed in the heart. Studies commenced 2 weeks after permanent myocardial infarction, to ensure experiments, were conducted during the acute remodelling period but after the majority of inflammatory changes had subsided. 17 
Echocardiography
At 2 weeks post-surgery, echocardiography was performed to assess the degree of cardiac dysfunction. Animals were lightly anaesthetized with isoflurane and 2D-echocardiography was performed as described previously. 18 Images were acquired at the mid-papillary level, and enddiastolic and end-systolic frames from three consecutive heart cycles were analysed. Measurements of end-diastolic and end-systolic areas and diameter were used to determine ejection fractions (end-diastolic area 2 end-systolic area/end-diastolic area) and fractional shortening (end-diastolic diameter 2 end-systolic diameter/end-diastolic diameter). 18 
Mitochondrial isolation
One day after echocardiography, hearts were excised, heart wet weight measured, and the necrotic infarct region removed and discarded. Most of the remaining left ventricular free wall and septum was used for mitochondrial isolation, but a biopsy was snap frozen in liquid nitrogen for subsequent analysis. SSM and IFM were isolated according to Palmer et al.,
8 using a modified Chappell -Perry buffer (100 mM KCl, 50 mM MOPS, 5 mM MgSO 4 . 7H 2 O, 1 mM EDTA, 1 mM ATP, and 0.2% BSA, pH 7.4). SSM were isolated by polytron and Potter-Elvejhem homogenization, and IFM were isolated using trypsin digestion (5 mg/gww) and further homogenization. Mitochondria were resuspended in KME (100 mM KCl, 50 mM MOPS, and 0.5 mM EGTA, pH 7.4) and protein concentrations were determined (BCA protein assay detection kit, Pierce, UK). The technique has been extensively validated to confirm that the isolation procedure separates the two mitochondrial populations.
-10
Measurement of mitochondrial respiration
Mitochondrial respiration was measured using a Clark-type oxygen electrode (Strathkelvin, UK) at 308C 19 as described previously. 6 Mitochondria were incubated in respiratory media (100 mM KCl, 50 mM MOPS, 1 mM EGTA, 5 mM KH 2 PO 4 , and 1 mg/mL BSA, pH 7.4) 8 and respiration was measured using a range of substrates that enter metabolic pathways at various locations. Respiration was measured using palmitoyl CoA (40 mM) with carnitine (5 mM) and malate (5 mM), palmitoyl carnitine (40 mM) with malate, b-hydroxybutyrate (1 mM) with malate, and glutamate (20 mM). 19, 20 State 3 (100 nmol ADP-stimulated) respiration, ADP-maximally stimulated (1000 nmol) respiration, state 4 (ADP-limited) respiration, ADP/O ratios (ADP phosphorylated per oxygen atom consumed), and respiratory control ratios (RCR; state 3/state 4 respiration) were measured as described previously. 6 Mitochondrial studies were performed blinded to the echocardiography results.
Western blotting
Protein levels were measured in both left ventricular and mitochondrial homogenates, using SDS -PAGE and western blotting as described previously. 4 Equal concentrations of protein were loaded and separated on 12.5% SDS -PAGE gels and transferred onto Immobilon-P membranes (Millipore, UK). Mitochondrial fatty acid translocase (FAT/CD36) was detected with an antibody donated by Dr Narendra Tandon (Otsuka Maryland Medicinal Laboratories, USA). Citrate synthase was detected using a primary antibody purchased from Alpha Diagnostics (USA). Primary antibodies against adenine nucleotide translocase (ANT), medium chain acyl-coenzyme A dehydrogenase (MCAD), peroxisome proliferator-activated receptor g coactivator 1 (PGC1a), a-ketoglutarate dehydrogenase, and the muscle isoform of carnitine palmitoyl transferase 1 (CPT1) were L.C. Heather et al.
purchased from Santa Cruz (USA). Antibodies raised to complexes I-V of the ETC were purchased from MitoSciences (USA), and to cytochrome c were purchased from BD Biosciences (USA). Even protein loading and transfer were confirmed by Ponceau staining, and protein levels were related to internal standards to ensure homogeneity between samples and gels. Bands were quantified using UN-SCAN-IT gel software (Silk Scientific, USA), and all samples were run in duplicate on separate gels to confirm results.
Complex III activity
Complex III activity was measured in freeze-thawed SSM and IFM. 14 To 1 mL of assay buffer (50 mM potassium phosphate, 3 mM sodium azide, 1.5 mM rotenone, and 50 mM cytochrome c, pH 7.2, 308C), 20 mg of mitochondria was added. The reaction was started by addition of 30 mM decylubiquinol and was measured spectrophotometrically at 550 nm for 1 min at 308C. The activity was calculated using the extinction coefficient of 19.1 mM 21 cm
21
. Decylubiquinol was synthesized as described by Paradies et al. 21 
Cardiolipin
Lipid extraction and cardiolipin analysis were performed as described by Valianpour et al. 22 with minor modifications. To 1 mL of whole cardiac homogenate, containing 500 mg protein, 1 nmol of internal standard (14 : 0) 4 -CL (Avanti Polar Lipids Inc., USA) was added.
Lipids were extracted using a modified Folch extraction and the combined organic layers were evaporated to dryness under nitrogen. Samples were resuspended in 500 mL sample buffer, which was a 50 : 50 v/v mix of solutions A and B [Solution A (v/v) contains 15% water, 85% methanol, and 0.1% of 250 mL/L aqueous ammonia solution; Solution B (v/v) contains 97% chloroform, 3% methanol, and 0.1% of 250 mL/L aqueous ammonia solution]. Samples were analysed by LC/MS/MS using a Waters 2795 separation unit and a Quattro micro API triple quadrupole mass spectrometer. Samples (10 mL) were injected onto the HPLC column (Supleco silica phase column, 25 cm Â 2.1 mm, 5 mm pore size, maintained at 258C) and separated using a gradient (5% A at 0 min to 100% A at 4 min, 100% A from 4 to 9 min, and 5% A at 9.5 -15 min) with a flow rate of 250 mL/min. The mass spectrometer was operated in negative ion mode with nitrogen as the nebulizing gas and argon as the collision gas; capillary voltage was 3.3 kV, cone voltage was 35 V, and source temperature was 1308C. The dominant form of cardiolipin in these samples was (C18 : 2) 4 -CL (m/z ¼ 723) and was analysed by assessing its fragmentation to a C18 : 2 fatty acid (m/z ¼ 279)-723.279 transition. The internal standard (C14 : 0) 4 -CL (m/z 619) was analysed using the transition 619.227. (C18 : 2) 4 -CL was quantified by reference to a standard curve of (C18 : 2) 4 -CL vs. (C14 : 0) 4 -CL. QuantLynx software (Waters) was used to perform data analysis and results are expressed as nmol/mg protein.
Detection of H 2 O 2 production
Submitochondrial particles (SMP) were generated from IFM by repeated freeze thawing and vigorous mixing. Hydrogen peroxide (H 2 O 2 ) production from SMP was measured using the fluorogenic indicator amplex red (10 mM) in combination with horseradish peroxidase (0.1 U/mL) (Amplex Red Hydrogen Peroxide assay kit, Invitrogen Molecular Probes, UK), as a marker for ROS generation. Fluorescence was measured in 96-well plates using a microplate reader (Fluostar Optima, BMG Labtech, UK), with 544 nm excitation and 590 nm emission wavelengths at 378C, and was linear over a 30 min period. Standard curves ranging from 0 to 5 mM H 2 O 2 were run with each experiment and were used to calculate the rate of H 2 O 2 generation from the SMP.
Background fluorescence was measured and subtracted from all values. H 2 O 2 production from SMP (8 mg) was measured using a range of substrates and inhibitors. 14,23 NADH (40 mM) was used as a specific complex I substrate, with H 2 O 2 generated from complexes I and III. Succinate (40 mM) with rotenone (2.4 mM) were used to feed electrons through complexes II to III while inhibiting back flow of electrons into complex I, localizing any H 2 O 2 generation to complex III. Antimycin A (10 mM) inhibits electron flow past the Qi centre of complex III, a major site of ROS production during ischaemia. 14 Malonate (10 mM) was used as a competitive inhibitor of complex II, confirming that ROS generation with succinate was specific to flux from complex II onwards. Using SMP allowed amplex red to detect H 2 O 2 produced on both sides of the inner mitochondrial membrane, and ensured that detection was not influenced by cellular antioxidants. 24 
Statistics
Data are presented as means + SEM and were analysed using one-way ANOVA and Tukey's post hoc analysis (SPSS 15.0 for windows). Correlation analysis was performed using Pearson's two-tailed bivariate correlation. Results were considered significant at P , 0.05.
Results
Cardiac function and physical characteristics
Myocardial infarction impaired cardiac function in all rats, with ejection fractions ranging from 22 to 58% at 2 weeks post-surgery. Infarcted rats were divided into two groups according to the severity of cardiac dysfunction, classified as moderately impaired when ejection fractions were .45% or classified as failing when ejection fractions were 45%. 6 Average ejection fractions in sham-operated control rats were 67%, which were reduced to 51% in moderately impaired hearts and to 32% in failing hearts ( Table 1) . Fractional shortening was reduced from 54% in sham-operated hearts to 25% in moderately impaired hearts and 16% in failing hearts. End-diastolic and end-systolic areas were significantly increased in failing hearts compared with sham-operated hearts. There were no significant differences in body weights or heart weights between groups. However, heart weight to body weight ratios were significantly increased in failing hearts compared with both sham-operated and moderately impaired hearts.
Mitochondrial yield
Total cardiac protein concentrations were no significantly different between groups (160 + 7 mg/gww in sham-operated hearts, 168 + 7 mg/gww in moderately impaired hearts, and 170 + 5 mg/gww in failing hearts). The yields of SSM and IFM isolated from rat hearts were not significantly different between groups, indicating mitochondrial content was not modified at 2 weeks post-myocardial infarction ( Table 2) . To confirm this, key mitochondrial proteins were measured in whole heart homogenates. Cardiac protein levels of Krebs cycle enzymes, citrate synthase and a-ketoglutarate dehydrogenase, were not significantly different between groups. In addition, protein levels of PGC1a, a regulator of mitochondrial biogenesis, were not significantly different between groups at 2 weeks post-myocardial infarction.
Mitochondrial respiration with fatty acid substrates
Mitochondrial respiration was measured using palmitoyl CoA as a substrate, to determine if mitochondrial fatty acid oxidation was impaired following myocardial infarction ( Table 3) . In failing hearts, state 3 respiration rates were reduced by 26 and 25% in SSM and IFM, respectively, compared with shams. State 4 respiration rates were reduced by 33 and 26% in SSM and IFM from failing hearts. Maximal ADP-stimulated respiration rates were reduced by 28 and 27% from SSM and IFM, respectively, from failing hearts compared with shams. ADP/O ratios and RCR were not significantly different between groups. In contrast, in hearts with moderately impaired function, there was no significant difference in mitochondrial respiration compared with sham-operated hearts. Thus, fatty acid respiration was impaired in mitochondria from failing hearts under both phosphorylating and non-phosphorylating conditions, but not from hearts with moderately impaired cardiac function at 2 weeks post-myocardial infarction.
Measuring respiration with palmitoyl carnitine bypasses the regulated mitochondrial fatty acid uptake step, controlled by CPT1 and FAT/CD36, 25 so by comparison with palmitoyl CoA can be used to determine if mitochondrial fatty acid uptake is defective. Using palmitoyl carnitine, state 3 respiration rates in both SSM and IFM populations were significantly reduced by 38 and 35%, respectively, from failing hearts compared with shams ( Table 3 ). In addition, state 3 respiration rates in both mitochondrial populations correlated positively with in vivo cardiac ejection fraction (Figure 1) , demonstrating that the decrease in mitochondrial fatty acid respiration was associated with the degree of cardiac impairment. State 4 respiration rates and maximal ADP-stimulated respiration rates were also significantly reduced by between 27 and 39% in mitochondria from failing hearts compared with shams ( Table 3) . ADP/O ratios and RCR were not significantly different between groups. Mitochondrial respiration from failing hearts was reduced by a similar percentage using palmitoyl carnitine as using palmitoyl CoA, indicating that mitochondrial fatty acid uptake was not defective or responsible for decreased respiration. This was further confirmed by measuring protein levels of FAT/CD36 and CPT1 in isolated mitochondria, which were found to be unchanged between sham-operated, moderately impaired, and failing hearts (Figure 2 ).
Mitochondrial respiration with Krebs cycle substrates
b-Hydroxybutyrate is a fatty acid-derived substrate that enters the Krebs cycle as acetyl CoA, but bypasses b-oxidation, therefore can be used to determine if b-oxidation is impaired. Rates of respiration with b-hydroxybutyrate are lower than with other substrates due to the rate-limiting uptake of ketone bodies across the mitochondrial membrane. 26 Using b-hydroxybutyrate, state 3 respiration rates in both SSM and IFM were decreased by 25%, and Mitochondrial respiration in the infarcted heart maximal ADP-stimulated respiration rates decreased by 23-25% from failing hearts compared with shams ( Table 4) . State 4 respiration rates were significantly decreased by 26% in IFM from failing hearts, whereas ADP/O ratios and RCR were unchanged between groups. Thus, there were similar percentage reductions in respiration rates with b-hydroxybutyrate when compared with palmitoyl CoA and palmitoyl carnitine, indicating that the defect was not located within b-oxidation, but instead located downstream from acetyl CoA. This was further confirmed by measuring mitochondrial protein levels of MCAD, a key b-oxidation enzyme, which was not significantly different between groups (Figure 2) . Glutamate assesses the second span of the Krebs cycle, comprising of a-ketoglutarate dehydrogenase and the subsequent entry of NADH into the ETC. 12 Using glutamate, state 3 and maximal ADP-stimulated respiration rates were significantly reduced in SSM and IFM from failing hearts by 20-27%, compared with sham-operated hearts ( Table 4) . State 4 respiration rates were similarly reduced by 30-34% in mitochondria from failing hearts, whereas ADP/O ratios and RCR did not differ between groups. These results suggest that the defect in respiration was still present when the first span of the Krebs cycle was bypassed, and was confirmed by the unchanged protein levels of citrate synthase measured in isolated mitochondria from sham-operated, moderately impaired, and failing hearts ( Figure 2) . Mitochondrial protein levels of a-ketoglutarate dehydrogenase were also unchanged between groups, indicating that the respiratory defect was not located within the Krebs cycle but instead must be located within the ETC. In mitochondria isolated from hearts with a moderate impairment in cardiac function, there was no defect in respiration with any of the substrates tested, compared with sham-operated control hearts.
ETC analysis and defective complex III activity
There were no significant differences in protein levels of complexes I, II, IV, V, and ANT in SSM and IFM between sham-operated, moderately impaired, and failing hearts (Figure 3) , and there were no correlations with ejection fractions (data not shown). However, complex III protein levels were significantly decreased by 47 and 44% in SSM and IFM, respectively, from failing hearts compared with shams ( Figure 4) . The activity of complex III was similarly reduced, decreased by 30 and 22% in SSM and IFM, respectively, from failing hearts. Mitochondrial complex III activity correlated positively with ejection fraction; thus, the hearts with the greatest functional impairment had the lowest activity of complex III. This was accompanied by reduced mitochondrial cytochrome c protein levels, decreased by 59 and 61% in SSM and IFM from failing hearts, demonstrating that not only was the activity of complex III impaired but the capacity to transport electrons from complex III to complex IV was also defective.
Cardiac cardiolipin content
Cardiolipin resides almost exclusively within the mitochondrial membrane and is essential for maintaining the activity of complex III and for retaining cytochrome c within the inner membrane. 27 There was no significant differences in cardiac cardiolipin content following myocardial infarction (13.5 + 0.6 nmol/mg protein in sham-operated hearts, 12.7 + 0.5 nmol/mg protein in moderately impaired infarcted hearts and 11.7 + 0.7 nmol/mg protein in failing hearts, P ¼ 0.1). However, when cardiolipin content was correlated with in vivo cardiac ejection fraction, a significant positive correlation was found; thus, hearts with the greatest cardiac dysfunction had the lowest cardiac cardiolipin content ( Figure 5 ).
H 2 O 2 production from SMP
Complexes I and III of the ETC are the major sites of ROS generation in the heart. H 2 O 2 production with NADH as a substrate was significantly increased by 30% in SMP from failing hearts compared with shams ( Figure 6 ). Blocking electron flow in complex III with antimycin A increased ROS production in all groups. However, H 2 O 2 production was 18% greater in SMP from failing hearts compared with shams. When H 2 O 2 production was specifically localized to complex III using succinate, rotenone, and antimycin A, H 2 O 2 production in SMP from failing hearts was increased more than three-fold over sham-operated hearts. H 2 O 2 generation (with succinate, rotenone, and antimycin A) correlated negatively with ejection fraction (P , 0.05, r ¼ 20.56); thus, hearts with the greatest functional impairment had the highest levels of complex III-specific ROS production. Addition of malonate to succinate and antimycin A prevented H 2 O 2 production from all SMP groups, confirming that the ROS was being generated specifically by flow through complex III.
Discussion
In this study, we have shown that mitochondrial respiration was impaired at 2 weeks post-myocardial infarction, and that the extent of respiratory dysfunction correlated with the degree of contractile dysfunction. The respiratory defect was localized to decreased complex III activity, and was associated with decreased mitochondrial cytochrome c and cardiolipin contents and resulted in increased ROS production.
Mitochondrial respiration and the relationship with cardiac dysfunction
In SSM and IFM from failing hearts, respiration rates were impaired with all substrates tested. The degree of mitochondrial dysfunction was similar between SSM and IFM, demonstrating that ischaemia-induced damage in the infarcted rat heart was not selective to the location of the mitochondria, whether located below the sarcolemma or between the myofilaments. Our non-discriminatory mitochondrial suppression of metabolism contrasts with the selective impairment in IFM respiration observed in the aged rat heart, signifying that the different mitochondrial populations are susceptible to different pathological stimuli. 28, 29 As SSM and IFM can be modulated independently in certain disease states, it is essential to investigate the two mitochondrial populations independently. This study investigated the relationship between cardiac dysfunction and mitochondrial dysfunction following myocardial infarction. By using the same model, surgical procedure, and mitochondrial respiratory protocol, we ensured that the only variable between rats was the extent of cardiac damage and contractile dysfunction. In our failing hearts, respiration rates were suppressed in both SSM and IFM with all substrates tested. Mitochondrial respiration rates with palmitoyl CoA were decreased by 26% in mitochondria isolated from our failing hearts, and palmitoyl carnitine-stimulated state 3 respiration rates correlated with in vivo ejection fraction. Thus, there was a positive relationship between mitochondrial function and cardiac function, and hearts with the greatest contractile impairment had the lowest rates of mitochondrial respiration. These data closely mirror the results obtained in the perfused, chronically infarcted rat heart, in which fatty acid oxidation rates were decreased by 30% and correlated positively with ejection fraction. 4 Therefore, whether measured at the subcellular or at the whole organ level, there was a strong positive relationship between oxidative metabolism and cardiac function. Mitochondria from failing hearts had impaired respiration rates with all substrates, yet mitochondria from hearts with moderately impaired function exhibited no defect in respiration, with rates comparable to sham-operated hearts. Our contrasting results between moderately impaired and failing hearts may explain why some studies have identified mitochondrial defects in heart disease and others have not, simply due to differences in the amount of cardiac damage induced by the surgery. 12, 13, 30 In other studies that have reported no significant differences in respiration rates, 13,31 the contractile dysfunction induced may have been comparable to our moderate severity infarction group.
Impaired respiration is associated with defects in complex III and cytochrome c
In failing hearts, respiration was impaired by a similar percentage with all substrates, with suppression of oxygen consumption ranging from 20 to 38% under phosphorylating conditions. All substrates converge at the ETC and, taken together with the unchanged b-oxidation and Krebs cycle proteins, this localized our defect to the ETC. Further investigation into protein levels of the respiratory complexes localized the defect specifically to complex III. This is a key difference between our 2-week postinfarction hearts and the chronically infarcted rat heart. Following chronic infarction, defects in b-oxidation, Krebs cycle, and ETC proteins have all been identified, whereas at 2-week postinfarction, we found no evidence of decreases in any other metabolic proteins except those in the vicinity of complex III. 4, 6, 7, 31 This raises the possibility that ischaemia-induced down-regulation of complex III may initiate the overall down-regulation of various proteins and metabolic pathways in the infarcted heart. Complex III is located at the crossroads of the ETC, independently receiving electrons from complexes I and II, and via the Q cycle transferring them to cytochrome c. Global ischaemia in the Langendorff-perfused, isolated heart has been shown to immediately impair complex III activity and mitochondrial function. 32 At this early time point, the content of complex III protein was not reduced, but the activity was suppressed due to inactivation of the iron-sulfur cluster within complex III. 29 Thus, it is plausible that the decreased complex III protein content in our infarcted hearts 2-week post-surgery may be a consequence of the initial impairment in the iron -sulfur protein occurring as a consequence of the ischaemic insult. 29, 32 A number of mitochondrial proteases have been identified that degrade oxidatively modified mitochondrial proteins, and these may mediate the decrease in the impaired complex III protein following myocardial infarction. 33 4.3 Impaired respiration is associated with increased ROS and cardiolipin deficiency H 2 O 2 production was significantly increased in mitochondria from our failing hearts and increased further when electron flow was blocked at complex III, suggesting an increased susceptibility to electron leak from complex III in heart failure. Complex III is the major site of ROS generation in mitochondria following ischaemia, 14 and ROS would be expected to induce most damage in the environment immediately surrounding its point of generation. 34 Inducing ROS generation in isolated mitochondria has been shown to specifically decrease complex III activity. 21 This decreased complex III activity was fully reversed when mitochondria were supplemented with exogenous cardiolipin, strongly implicating cardiolipin loss as the mechanism for ROS-induced reduction in complex III activity. 21 Cardiolipin is located within the inner mitochondrial membrane surrounding complex III, and its location, in combination with its highly unsaturated structure, make it a prime target for oxidative damage by ROS. 27 In our infarcted hearts, cardiolipin content correlated with ejection fraction, demonstrating that the hearts with the greatest impairment in cardiac function had the lowest cardiolipin content, in addition to the highest ROS generation and lowest complex III activity. In addition to the important role of cardiolipin in maintaining complex III activity, 32 cardiolipin is also important for maintaining cytochrome c within the inner membrane. 27 Loss of cardiolipin would be expected to result in loss of mitochondrial cytochrome c, a result also found in our failing hearts at 2-week post-surgery. Thus, we hypothesize that myocardial ischaemia induced by infarction increased ROS from complex III, caused peroxidation, and loss of cardiolipin (and possibly direct damage to complex III). Loss of cardiolipin directly leads to loss of complex III activity and cytochrome c, thereby impairing respiration and increasing ROS generation further in the infarcted heart. 14, 32, 35 This proposed mechanism would account for our findings in the failing heart at 2-week post-myocardial infarction. As ROS generation, cardiolipin content, complex III activity, and mitochondrial respiration all correlated with ejection fraction, it would suggest that this mechanism occurs to a greater extent in hearts following a severe infarct than in hearts following a mild infarct.
In conclusion, mitochondrial respiration was impaired in failing hearts 2 weeks after myocardial infarction, but not in hearts with a moderate impairment in cardiac function. Complex III is the primary site of metabolic dysfunction in mitochondria from failing hearts acutely after myocardial infarction and was associated with increased ROS generation, loss of cardiolipin, and impaired respiration. Correlations between mitochondrial metabolism and in vivo cardiac function confirm that mitochondrial metabolic abnormalities are dependent on the stage and severity of cardiac dysfunction.
